FTC Pulls OptumRx Insulin Price Case To Review Final Deal
By Bryan Koenig · June 15, 2026, 8:01 PM EDT
The Federal Trade Commission's third and final settlement resolving an in-house case accusing pharmacy benefit managers of inflating insulin prices through rebate schemes is in sight after the agency on Friday...
To view the full article, register now.